LEADER 02650nas 2200841-a 450 001 996204827103316 005 20230627152502.0 011 $a1365-2184 035 $a(OCoLC)42448498 035 $a(CKB)954925579099 035 $a(CONSER)--2010250600 035 $a(MiAaPQ)2045182 035 $a(EXLCZ)99954925579099 100 $a19990928a19919999 s-- - 101 0 $aeng 135 $aurmnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCell proliferation 210 $a3 1991- ;$a[Oxford] $cBlackwell Science Ltd 210 3 $a3 <2015-> ;$aOxford, UK $cJohn Wiley & Sons Ltd 300 $aRefereed/Peer-reviewed 311 $a0960-7722 531 $aCELL PROLIFERAT 531 $aCELL PROLIF 531 10$aCell prolif. 606 $aCell proliferation$vPeriodicals 606 $aCell cycle$vPeriodicals 606 $aCell cycle 606 $aCell Differentiation 606 $aSocieties, Medical 606 $aCellules$xProlifération$vPériodiques 606 $aCellules$xDifférenciation$vPériodiques 606 $aCycle cellulaire$vPériodiques 606 $aCytologie$vPériodiques 606 $aCell cycle$2fast$3(OCoLC)fst00850178 606 $aCell proliferation$2fast$3(OCoLC)fst00850224 606 $aCelcyclus$2gtt 606 $aCeldifferentiatie$2gtt 606 $aProlifération cellulaire$2rasuqam 606 $aDifférenciation cellulaire$2rasuqam 606 $aCycle cellulaire$2rasuqam 608 $aPeriodicals. 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aRessource Internet (Descripteur de forme)$2rasuqam 608 $aPériodique électronique (Descripteur de forme)$2rasuqam 615 0$aCell proliferation 615 0$aCell cycle 615 2$aCell cycle. 615 2$aCell Differentiation. 615 2$aSocieties, Medical. 615 6$aCellules$xProlifération 615 6$aCellules$xDifférenciation 615 6$aCycle cellulaire 615 6$aCytologie 615 7$aCell cycle. 615 7$aCell proliferation. 615 17$aCelcyclus. 615 17$aCeldifferentiatie. 615 7$aProlifération cellulaire. 615 7$aDifférenciation cellulaire. 615 7$aCycle cellulaire. 676 $a574.876 712 02$aEuropean Cell Proliferation Society, 712 02$aCell Kinetics Society, 712 02$aEuropean Study Group for Cell Proliferation, 712 02$aInternational Cell Cycle Society, 906 $aJOURNAL 912 $a996204827103316 996 $aCell proliferation$92091775 997 $aUNISA LEADER 05659nam 22006135 450 001 9910298396303321 005 20251113184522.0 010 $a981-10-8064-X 024 7 $a10.1007/978-981-10-8064-7 035 $a(CKB)3850000000032871 035 $a(DE-He213)978-981-10-8064-7 035 $a(MiAaPQ)EBC5471052 035 $a(PPN)229499813 035 $a(EXLCZ)993850000000032871 100 $a20180702d2018 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAnticancer Plants: Natural Products and Biotechnological Implements $eVolume 2 /$fedited by Mohd Sayeed Akhtar, Mallappa Kumara Swamy 205 $a1st ed. 2018. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2018. 215 $a1 online resource (XV, 564 p. 139 illus., 21 illus. in color.) 311 08$a981-10-8063-1 327 $aChapter 1. Fungal Endophytes as Novel Sources of Anticancer Compounds -- Chapter 2. Gastrointestinal Bezoar Stones: Current Knowledge and Future Pperspective on the Potential of Plant-derived Phytobezoar in Cancer Treatment -- Chapter 3. Potential of Natural Products for Prevention of Oral Cancer -- Chapter 4. Therapeutic Potential of Cardiac Glycosides Against Cancer -- Chapter 5. Conserving Biodiversity of a Potent Anticancer Plant, Catharanthus roseus Through In vitro Biotechnological Intercessions: Substantial Progress and Imminent Prospects -- Chapter 6. Medicinal Plants as a Potential Source of Chemopreventive Agents -- Chapter 7. Plant Metabolites as New Leads to Anticancer Drug Discovery: Approaches and Challenges -- Chapter 8. Terpenes of Genus Salvia: Cytotoxicity and Antitumoral Effects -- Chapter 9. Essential Oil with Anticancer Activity: An Overview -- Chapter 10. Fungal Endophytes from Anticancer Plants as Producers of the Anti-tumour Agent L-Asparaginase: A Look at Diversity, Ubiquity and Enzyme Production -- Chapter 11. Xylooligosaccharides and their Anticancer Potential: An Update -- Chapter 12. Phytochemicals Targeting Endoplasmic Reticulum Stress to Inhibit Cancer Cell Proliferation -- Chapter 13. Remedy of Targeting Cancer andCcancer Stem Cells with Botanicals -- Chapter 14. Therapeutic Strategies of Natural Agents and its Components on Triple-Negative Breast Cancer -- Chapter 15. Endophytic Microbes as a Novel Source for Producing Anticancer Compounds as Multidrug Resistance Modulators. Chapter 16. Traditional Medicinal Plants and their Therapeutic Potential Against Major Cancer Types -- Chapter 17. Platelet Derived Growth Factor Receptor (PDGF-R) as the Target for Herbal Based Anticancer Agents -- Chapter 18. Plant Cell and Organ Culture as an Alternative for the Production of Anticancer Compounds -- Chapter 19. Plant Derived Extracts and Compounds: An Alternative Therapy Against Breast Cancer -- Chapter 20. Micropropagation and Conservation of Selected Endangered Anticancer Medicinal Plants from the Western Ghats of India -- Chapter 21. Biotechnological Approaches for the Propagation of Anticancer Plants and the Production of Vital Compounds -- Chapter 22. An Alternative Approach for Anticancer Compounds Production Through Plant Tissue Culture Techniques -- Chapter 23. Biotechnological Intervention Through Tissue Culture in Hedychium coronarium: A Potential Anticancer Plant. . 330 $aThis volume provides summarized scientific evidence of the different classes of plant-derived phytocompounds, their sources, chemical structures, anticancer properties, mechanisms of action, methods of extraction, and their applications in cancer therapy. It also discusses endophyte-derived compounds as chemopreventives to treat various cancer types. In addition, it provides detailed information on the enhanced production of therapeutically valuable anticancer metabolites using biotechnological interventions such as plant cell and tissue culture approaches, including in vitro-, hairy root- and cell-suspension culture; and metabolic engineering of biosynthetic pathways. Anticancer Plants: Natural Products and Biotechnological Implements ? Volume 2? explores the natural bioactive compounds isolated from plants as well as fungal endophytes, their chemistry, and preventive effects to reduce the risk of cancer. Moreover, it highlights the genomics/proteomics approaches and biotechnological implementations. Providing solutions to deal with the challenges involved in cancer therapy, the book benefits a wide range of readers including academics, students, and industrial experts working in the area of natural products, medicinal plant chemistry, pharmacology, and biotechnology. 606 $aPlant physiology 606 $aAgriculture 606 $aProteins 606 $aPlant genetics 606 $aCancer 606 $aPlant Physiology 606 $aAgriculture 606 $aProtein Biochemistry 606 $aPlant Genetics 606 $aCancer Biology 615 0$aPlant physiology. 615 0$aAgriculture. 615 0$aProteins. 615 0$aPlant genetics. 615 0$aCancer. 615 14$aPlant Physiology. 615 24$aAgriculture. 615 24$aProtein Biochemistry. 615 24$aPlant Genetics. 615 24$aCancer Biology. 676 $a616.9940072 702 $aAkhtar$b Mohd. Sayeed$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aKumara Swamy$b Mallappa$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910298396303321 996 $aAnticancer Plants: Natural Products and Biotechnological Implements$92496865 997 $aUNINA